How to succeed at Senior Level Interview

01/03/2016


Attending interviews for Senior positions can be extremely challenging. It’s no longer good enough to just talk about your experience in detail – you also need to describe your management style, outline your vision and prove your ability.




Answer the questions

Listen carefully to what your interviewer is asking and spend time planning your answers. Interviewees at executive level have to demonstrate an understanding of a company’s needs and how they can address them. In many cases the role will be a new one, and your interviewer will be assessing...


How to succeed at Senior Level Interview

01/03/2016


Attending interviews for Senior positions can be extremely challenging. It’s no longer good enough to just talk about your experience in detail – you also need to describe your management style, outline your vision and prove your ability.
Answer the questions

Listen carefully to what your interviewer is asking and spend time planning your answers. Interviewees at executive level have to demonstrate an understanding of a company’s needs and how they can address them. In many cases the role will be a new one, and your interviewer will be assessing why you are the person to...


The Benefits of using a Recruiter in your Job Search

07/08/2013

There’s a lot of truth to the old saying that looking for a job is a full-time job in itself. The job search takes place on many fronts, CV and interview preparation, online job board applications, emails to employers, building a social media brand, attending networking events and training programmes to name just a few. It’s fair to say that a dedicated jobseeker has their hands full if they are engaged in the majority of these activities.
However, many candidates ignore the enormous benefits and resources available to them through the use of a recruitment company. For starters,...


3 ways to build a great relationship with your recruiter

27/03/2013

Written by Dave Cullen


When you are in the market for a new job, there is no better way to maximise your potential opportunities than building a strong and productive relationship with a job recruiter. Before we begin, it is important to dispel a few common myths about recruiters. Firstly, their job is not to find you a suitable role, their job is to match the available opportunities of their clients with the best possible candidates they can find. This is an important distinction to make because simply calling a recruiter and asking them if they have any suitable jobs is...


How to improve your Time Management in the workplace

05/10/2012

According to a recent survey the number one complaint amongst employees in the modern workplace is the poor time management of their colleagues. We are all occasionally guilty of not utilising our time at work effectively. We allow ourselves to become unnecessarily overwhelmed by the myriad of activities we have to attend to, and fail to adequately perform at any of them particularly well. The pressure to meet razor thin deadlines and succeed in producing successful projects, can easily allow us to cause our personal organisational standards to drop below par.


Thankfully,...


GLOBAL BIO PHARMA SUMMIT 2012

05/10/2012

2012 theme: Competitiveness through Innovation in Pharma Manufacturing & Research.
The Summit has been established by industry as an independent annual platform. This is the must be at event for the Irish Pharma & Development Sector, from Site Managers to the research bench.


Using Pinterest to find a job

26/09/2012


Using Pinterest to find a job


0 comments2012/09/21blogeditor


inShare20













Tweet






-->



So far in our discussion of the power of social media platforms for job seeking, we have looked at Facebook, Linkedin and Google+. All of these online mass communication services provide a unique range of...


Alchemist Aperitif will host open conversations & debates with speakers at the ESOF Conference

05/07/2012


The Future of Recruitment

13/03/2012

CPL/Thornshaw Scientific hosted a talk recently on the Future of Recruitment.




The event was hosted in the Science Gallery by Peter Cosgrove, Director of Cpl on the 28th of February with over 150 industry leaders in attendance. Topics covered during the presentation included the latest trends in recruitment, best practice case studies to help companies maximise ROI and some of the most effective ways of attracting top talent. To view the presentation, just click on the slides below.

Outlined in the presentation;


The importance of...


Abbott to invest €85 million in the expansion of its Sligo pharmaceutical manufacturing facility

10/02/2012

Abbott plans to invest €85 million at its pharmaceutical manufacturing operation in Sligo. The investment will result in the creation of up to approximately 175 highly skilled jobs.  The expansion of the facility will be completed in 2014.



The expansion will provide additional space for manufacturing operations to support Abbott’s future pharmaceutical pipeline in the key therapeutic areas of virology, oncology and nephrology and provide additional capacity in Abbott's global pharmaceutical manufacturing network.  The new jobs that will be created will be...


Allianz Worldwide Care to create 128 new jobs in Dublin

10/10/2011


DUBLIN, Monday, 10th October, 2011:  Following the creation of 50 new jobs in Ireland announced in July this year, Allianz Worldwide Care has announced a further 128 positions, to be filled immediately at the company’s headquarters in Park West.
Welcoming today’s announcement Barry O’Leary, IDA Ireland CEO said ‘We are delighted that Allianz has decided to create these additional jobs in Dublin. Allianz is a leading international health insurance company which has been going from strength to strength in Ireland. It is encouraging that today’s announcement follows a flow in...


MSD opens new €100m R&D centre in Tipperary

22/09/2011

September 22nd 2011: “This strategically important development for MSD which brings R&D and high-value jobs to our economy is a significant endorsement of Ireland’s wealth of talent and expertise,” said the Taoiseach, Enda Kenny TD speaking at the official opening of the new €100m pharmaceutical R&D centre at MSD in Ballydine, Co. Tipperary. “The decision by this global healthcare leader to invest in Ireland in order to provide the capability to bring new innovative medicines to market faster is an endorsement of my government’s strategy to focus on job creation and the knowledge...


Pfizer set to invest $200m in its Dublin plant

22/09/2011


PHARMA GIANT Pfizer is investing a further $200 million at its Grange Castle plant in Dublin.





The US group is expanding the number of processing suites and the biotechnology manufacturing plant in Clondalkin to allow it increase production capacity.

The new units will facilitate more product testing.

Grange Castle is one of the largest biotech manufacturing sites worldwide, employing 1,100 staff.





It produces two of the US group’s blockbuster drugs – the pneumococcal vaccine Prevenar and the...


Pfizer Announces New Strategic Partnerships with ICON and PAREXEL International Corporation

30/05/2011

Pfizer Inc. announced strategic partnerships with ICON plc and PAREXEL International Corporation, both of which will serve as strategic providers of clinical trial implementation services over a five-year period beginning in June 2011. The new partnerships will be fully implemented over an 18-to-24 month period.

The ICON and PAREXEL alliances reflect Pfizer's recent commitment to strengthen the performance of its innovative core. Pfizer announced in February a comprehensive program of change in R&D to sharpen research focus, deliver differentiated innovation, and create a more...


Alkermes purchased Elan’s Elan Drug Technologies (EDT)

13/05/2011


Alkermes purchased Elan’s Elan Drug Technologies (EDT) unit in a cash and stock transaction worth approximately $960 million. The two companies will be merged into a new holding company in Ireland under the name Alkermes plc.

A press statement explained that Elan will receive $500 million in cash and $31.9 million in ordinary shares of the new company’s common stock. Alkermes believes that the transaction will be immediately accretive to its cash earnings. The combined company is expected to have annual growing product, royalty, and manufacturing revenues in excess of $450...


Merck and Its Employees to Donate to Japanese Relief Effort

29/03/2011


Merck KGaA announced that in order to provide assistance to the Japanese people following the earthquake and tsunami that devastated parts of their country, the company will donate a total of 100 million YEN (approximately EUR 875,000).



The major part of the donation will be given to the international relief organization "Save the Children". Merck's Japanese subsidiaries will decide how the remainder of the donation will be distributed. The region around Onahama, where one of Merck's production sites is located and which is close to the Fukushima nuclear power...


EU Parliament backs tougher counterfeit drugs laws

18/02/2011


A new law to prevent fake drugs from entering the supply chain has been approved by the European Parliament, covering internet sales and introducing new safety and traceability measures, as well as sanctions against counterfeiters.





The directive, which has been in the works for over two years and now needs to be ratified by the Council of Ministers, is designed to tackle the estimated 1% of medicinal products currently sold to the European public through the legal supply chain that are fake. Marisa Matias, a Portuguese MEP and the parliamentary...


Sanofi-aventis and Genzyme Corporation

18/02/2011

Sanofi-aventis and Genzyme Corporation announced recently that they have entered into a definitive agreement under which sanofi-aventis is to acquire Genzyme for $74.00 per share in cash, or approximately $20.1B. In addition to the cash payment, each Genzyme shareholder will receive one Contingent Value Right (CVR) for each share they own, entitling the holder to receive additional cash payments if specified milestones related to Lemtrada (alemtuzumab MS) are achieved over time or a milestone related to production volumes in 2011 for Cerezyme and Fabrazyme is achieved.


EI Pharma Networking Event, Irish Embassy, London

20/01/2011

This Enterprise Ireland networking reception, hosted by the Irish Embassy, will bring together senior decision makers and global pharma executives and will include delegates from the EIU Global Pharma Summit.



Date: Thursday 10th February 2011

Time: 17.00 -20.00



Takeda has made another move into the vaccines sector with the expansion of a deal with Baxter International for the use of a cell culture technology for making influenza vaccines.

07/12/2010

Takeda has made another move into the vaccines sector with the expansion of a deal with Baxter International for the use of a cell culture technology for making influenza vaccines.

The Japanese drugmaker has gained an exclusive licence in Japan for Baxter's proprietary Vero technology.

Traditionally, vaccines are manufactured using hens' eggs, but this process requires very large amounts of eggs and takes at least six months, making it difficult to keep up with a rapidly mutating virus. The Vero cell culture process can be initiated more rapidly thanks to its use of a...


Page 1 | 2